EULAV Asset Management’s US Physical Therapy USPH Stock Holding History

EULAV Asset Management’s Portfolio USPH Stock Details USPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-19,100	Closed	-$1.38M	–	166
2025 Q1	$1.38M	Sell	19,100 -6,600	-26%	-$554K	0.03%	162
2024 Q4	$2.28M	Sell	25,700 -18,000	-41%	-$1.6M	0.05%	159
2024 Q3	$3.7M	Sell	43,700 -31,900	-42%	-$2.83M	0.09%	137
2024 Q2	$6.99M	Sell	75,600 -2,200	-3%	-$223K	0.19%	115
2024 Q1	$8.78M	Hold	77,800	–	–	0.24%	101
2023 Q4	$7.25M	Hold	77,800	–	–	0.22%	103
2023 Q3	$7.14M	Hold	77,800	–	–	0.26%	93
2023 Q2	$9.44M	Hold	77,800	–	–	0.35%	78
2023 Q1	$7.62M	Hold	77,800	–	–	0.3%	89
2022 Q4	$6.3M	Hold	77,800	–	–	0.27%	96
2022 Q3	$5.91M	Hold	77,800	–	–	0.26%	101
2022 Q2	$8.5M	Hold	77,800	–	–	0.35%	79
2022 Q1	$7.74M	Hold	77,800	–	–	0.23%	109
2021 Q4	$7.8M	Hold	77,800	–	–	0.2%	131
2021 Q3	$8.61M	Hold	77,800	–	–	0.23%	117
2021 Q2	$9.02M	Hold	77,800	–	–	0.24%	109
2021 Q1	$8.1M	Hold	77,800	–	–	0.22%	115
2020 Q4	$9.36M	Hold	77,800	–	–	0.24%	120
2020 Q3	$6.76M	Hold	77,800	–	–	0.2%	123
2020 Q2	$6.3M	Hold	77,800	–	–	0.21%	119
2020 Q1	$5.37M	Hold	77,800	–	–	0.21%	117
2019 Q4	$8.9M	Buy	77,800 +800	+1%	+$99.6K	0.31%	92
2019 Q3	$10.1M	Buy	77,000 +5,300	+7%	+$690K	0.37%	84
2019 Q2	$8.79M	Buy	71,700 +7,300	+11%	+$839K	0.33%	94
2019 Q1	$6.88M	Buy	64,400 +9,300	+17%	+$1,000K	0.28%	105
2018 Q4	$5.64M	Buy	55,100 +10,800	+24%	+$1.2M	0.28%	108
2018 Q3	$5.25M	Buy	44,300 +2,000	+5%	+$226K	0.23%	124
2018 Q2	$4.06M	Hold	42,300	–	–	0.19%	139
2018 Q1	$3.44M	Hold	42,300	–	–	0.16%	163
2017 Q4	$3.05M	Buy	42,300 +600	+1%	+$40.9K	0.14%	174
2017 Q3	$2.56M	Buy	41,700 +400	+1%	+$24.4K	0.12%	185
2017 Q2	$2.5M	Hold	41,300	–	–	0.12%	190
2017 Q1	$2.7M	Buy	41,300 +4,400	+12%	+$312K	0.14%	191
2016 Q4	$2.59M	Buy	36,900 +7,500	+26%	+$477K	0.14%	197
2016 Q3	$1.84M	Buy	29,400 +8,400	+40%	+$518K	0.1%	208
2016 Q2	$1.26M	Buy	+21,000	New	+$1.15M	0.07%	232

Other funds holding USPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Southernsun Asset Management Memphis, Tennessee $690M AUM 30.68% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

EULAV Asset Management's USPH Position: Q2 2025 in Review

EULAV Asset Management sold out of US Physical Therapy (USPH) in Q2 2025, closing a stake of 19,100 shares — an estimated $1.38M sold.

EULAV Asset Management first reported a position in USPH in Q2 2016 and held it in 36 quarters. The position peaked at $10.1M in Q3 2019. 240 funds tracked by Wall St. Rank hold USPH as of Q2 2025.

EULAV Asset Management reported no remaining US Physical Therapy position as of Q2 2025 after selling out during the quarter.
EULAV Asset Management sold 19,100 US Physical Therapy shares in Q2 2025, an estimated $1.38M.
EULAV Asset Management first reported a position in US Physical Therapy in Q2 2016 and held it in 36 quarters.
EULAV Asset Management's US Physical Therapy position peaked at $10.1M in Q3 2019.
240 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2025.

Based on EULAV Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.